PACTR201606001665364已完成未知
A Double-blind Randomized Trial on the Effectiveness of Syferol - IHP® (A Special Blend of Virgin Coconut Oil and Cold-Pressed Ocimum sanctum Oil) for the Treatment of Peptic Ulcer Disease
Prof Maurice Iwu0 个研究点目标入组 60 人开始时间: 2016年6月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Year(s) 至 60 Year(s)（—）
- 性别
- All
入选标准
- •Both male and female individuals aged between 18-60 years.
- •Patients with confirmed diagnosis of peptic ulcer disease.
- •Patients with normal liver function tests, renal function tests and hematological profiles will be included.
排除标准
- •Patients refusal of consent to the study
- •Patients falling outside the age bracket of 18-60 years.
研究者
相似试验
进行中（未招募）
不适用
A Randomized, Double-Blind Trial Assessing the Efficacy and Safety of Etanercept 50 mg Twice Weekly and Etanercept 50 mg Once Weekly for the Treatment of Moderate to Severe PsoriasisEUCTR2007-001724-12-BEWyeth Pharmaceuticals France250
进行中（未招募）
不适用
A Randomized, Double-Blind Trial Assessing the Efficacy and Safety of Etanercept 50 mg Twice Weekly and Etanercept 50 mg Once Weekly for the Treatment of Moderate to Severe PsoriasisEUCTR2007-001724-12-ATWyeth Research Division of Wyeth Pharmaceuticals Inc.250
进行中（未招募）
不适用
A Randomized, Double-Blind Trial Assessing the Efficacy and Safety of Etanercept 50 mg Twice Weekly and Etanercept 50 mg Once Weekly for the Treatment of Moderate to Severe PsoriasisModerate to severe plaque psoriasisEUCTR2007-001724-12-GRWyeth Pharmaceuticals France250
进行中（未招募）
不适用
A Randomized, Double-Blind Trial Assessing the Efficacy and Safety of Etanercept 50 mg Twice Weekly and Etanercept 50 mg Once Weekly for the Treatment of Moderate to Severe Psoriasis - NDModerate to severe plaque psoriasisMedDRA version: 9.1Level: LLTClassification code 10050577Term: Psoriatic plaqueEUCTR2007-001724-12-ITWyeth Pharmaceutricals France Wyeth Research Division250
进行中（未招募）
不适用
A Randomized, Double-Blind Trial Assessing the Efficacy and Safety of Etanercept 50 mg Twice Weekly and Etanercept 50 mg Once Weekly for the Treatment of Moderate to Severe PsoriasisEUCTR2007-001724-12-CZWyeth Pharmaceuticals France250